vildagliptin
Overview
Categories
- 18 Hormones and other endocrine drugs and contraceptives
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Vildagliptin's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 50 to 50 mg | 50 (50) | 12 hourly | oral | When used in dual combination with metformin or a thiazolidinedione. It can be taken with or without food. No dose adjustment is required in patients with mild renal impairment (creatinine clearance GREATER-THAN OR EQUAL TO 50ml/min). The use of vildagliptin is not recommended in patients with moderate or severe renal impairment or in haemodialysis patients with end-stage renal disease (ESRD). |
| 50 to 100 mg | 75 (75) | 24 hourly | oral | When used in dual combination with a sulphonylurea it is recommended once daily. Doses higher than 100mg are not recommended. It can be taken with or without food. It is not recommended for use in children (less then 18 years) and adolescents due to a lack of data on safety and efficacy. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Vildagliptin is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Vildagliptin is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Vildagliptin
Back to top
Previous Drug Generic - Next Drug Generic